Lipids and Lipid Derivatives
Medchemexpress LLC Dihydrotanshinone I | 87205-99-0 | 278.30 | 5 MG
Dihydrotanshinone I is a natural compound extracted from *Salvia miltiorrhiza Bunge*. This compound has been extensively used for treating cardiovascular diseases and demonstrates an entry-blocking effect against MERS-CoV.
- Extracted from *Salvia miltiorrhiza Bunge*
- Used for treating cardiovascular diseases
- Exhibits entry-blocking effect for MERS-CoV
- Attenuates atherosclerosis in ApoE-/- mice
- Inhibits LOX-1, NOX4, and NF-κB expression in aorta
- Improves cardiac function and reduces infarct size in myocardial ischemia-reperfusion rats
- Induces caspase-dependent apoptosis and autophagy in colon cancer cells
- Potentially a safe, high-throughput screening compound for MERS-CoV entry inhibitors
- Purity: 99.57%
- Appearance: Solid, brown to red
Medchemexpress LLC Tanshinone IIA sulfonate (sodium) | 69659-80-9 | 396.39 | 25 MG
Tanshinone IIA sulfonate (sodium) is a derivative of tanshinone IIA, which acts as an inhibitor of store-operated Ca2+ entry (SOCE). This compound is primarily used to treat various cardiovascular disorders. It is supplied as a pink to red solid with a purity of 99.77%.
- Acts as an inhibitor of store-operated Ca2+ entry (SOCE).
- Used to treat cardiovascular disorders.
- Supplied as a pink to red solid.
- Purity of 99.77%.
- Shipped at room temperature within the continental US.
- Stored at 4°C in sealed containers, away from moisture.
- Unstable in solutions, fresh preparation is recommended for use.
Medchemexpress LLC Retinyl acetate Sta 100mg
Retinyl acetate (Standard) is the analytical standard of Retinyl acetate This product is intended for research and analytical applications Retinyl acetate is a synthetic acetate ester form derived from retinol and has potential antineoplastic and chemo preventive activities[1]
Apexbio Technology LLC DEGARELIX-ACETATE-100MG
Degarelix acetate (CAS No 934016-19-0) is a gonadotropin-releasing hormone (GnRH) antagonist used in biomedical research primarily for its role in androgen deprivation therapy Originating from synthetic peptides it functions by binding to GnRH receptors in the anterior pituitary gland effectively decreasing the release of luteinizing hormone and subsequently reducing testosterone production Its in vitro activity typically ranges from the nanomolar to low micromolar concentration Degarelix acetate is commonly applied in cell models and animal studies to investigate prostate cancer treatment and it is also used in drug screening for hormonal therapies Experimental concentrations typically depend on the specific research design offering flexibility in application across various studies